Author Edelmann, Frank

21 to 29 of 29 Items
  • 2022 | Journal Article
    ​ ​Evaluation of the HFA‐PEFF Score: results from the prospective DIAST‐CHF cohort​
    Hashemi, D.; Mende, M.; Trippel, T. D.; Petutschnigg, J.; Hasenfuss, G.; Nolte, K. & Herrmann‐Lingen, C. et al.​ (2022) 
    ESC Heart Failure, 9(6) art. ehf2.14131​.​ DOI: https://doi.org/10.1002/ehf2.14131 
    ​Details  DOI 
  • 2022 | Journal Article | 
    ​ ​Biomarker profiles in heart failure with preserved vs. reduced ejection fraction: results from the DIAST‐CHF study​
    Eidizadeh, A.; Schnelle, M.; Leha, A.; Edelmann, F.; Nolte, K.; Werhahn, S. M. & Binder, L. et al.​ (2022) 
    ESC Heart Failure, 10(1) art. ehf2.14167​.​ DOI: https://doi.org/10.1002/ehf2.14167 
    ​Details  DOI 
  • 2023 | Journal Article | 
    ​ ​Trans-fatty acid blood levels of industrial but not natural origin are associated with cardiovascular risk factors in patients with HFpEF: a secondary analysis of the Aldo-DHF trial​
    Lechner, K.; Bock, M.; von Schacky, C.; Scherr, J.; Lorenz, E.; Lechner, B. & Haller, B. et al.​ (2023) 
    Clinical Research in Cardiology,.​ DOI: https://doi.org/10.1007/s00392-022-02143-7 
    ​Details  DOI 
  • 2023 | Journal Article
    ​ ​De Novo Lipogenesis-Related Monounsaturated Fatty Acids in the Blood Are Associated with Cardiovascular Risk Factors in HFpEF Patients​
    Bock, M.; von Schacky, C.; Scherr, J.; Lorenz, E.; Lechner, B.; Krannich, A. & Wachter, R. et al.​ (2023) 
    Journal of Clinical Medicine, 12(15) pp. 4938​.​ DOI: https://doi.org/10.3390/jcm12154938 
    ​Details  DOI 
  • 2023 | Journal Article
    ​ ​Repurposing the β 3 -Adrenergic Receptor Agonist Mirabegron in Patients With Structural Cardiac Disease​
    Balligand, J.-L.; Brito, D.; Brosteanu, O.; Casadei, B.; Depoix, C.; Edelmann, F. & Ferreira, V. et al.​ (2023) 
    JAMA Cardiology,.​ DOI: https://doi.org/10.1001/jamacardio.2023.3003 
    ​Details  DOI 
  • 2023 | Journal Article
    ​ ​Supervised exercise training in patients with advanced heart failure and left ventricular assist device: A multicentre randomized controlled trial ( Ex‐VAD trial)​
    Feuerstein, A.; Schoenrath, F.; Belyavskiy, E.; Knierim, J.; Friede, T.; Placzek, M. & Bach, D. et al.​ (2023) 
    European Journal of Heart Failure, art. ejhf.3032​.​ DOI: https://doi.org/10.1002/ejhf.3032 
    ​Details  DOI 
  • 2023 | Journal Article
    ​ ​Erhalt von Leistungsfähigkeit und Lebensqualität bei chronischer Herzinsuffizienz (Teil 3)​
    von Haehling, S.; Arzt, M.; Doehner, W.; Edelmann, F.; Evertz, R.; Ebner, N. & Herrmann-Lingen, C. et al.​ (2023) 
    Die Kardiologie, 17(1) pp. 50​-62​.​ DOI: https://doi.org/10.1007/s12181-023-00593-5 
    ​Details  DOI 
  • 2023 | Journal Article
    ​ ​Treatment response to spironolactone in patients with heart failure with preserved ejection fraction: a machine learning-based analysis of two randomized controlled trials​
    Kresoja, K.-P.; Unterhuber, M.; Wachter, R.; Rommel, K.-P.; Besler, C.; Shah, S. & Thiele, H. et al.​ (2023) 
    EBioMedicine, 96 art. 104795​.​ DOI: https://doi.org/10.1016/j.ebiom.2023.104795 
    ​Details  DOI 
  • 2023 | Journal Article | 
    ​ ​Longitudinal association between N-terminal B-type natriuretic peptide, anxiety and social support in patients with HFpEF: results from the multicentre randomized controlled Aldo-DHF trial​
    Wilke, M. R.; Broschmann, D.; Sandek, A.; Wachter, R.; Edelmann, F. & Herrmann‐Lingen, C. ​ (2023) 
    BMC Cardiovascular Disorders, 23(1) art. 184​.​ DOI: https://doi.org/10.1186/s12872-023-03136-8 
    ​Details  DOI 

Researcher

Göttingen All

Sort

issue date

ASC DESC

Items per Page

10 20 50 100